Two Covid Vaccines Funded by Warp Speed Are Finally Near the Finish Line, But Does Anyone Still Need Them?
Novavax and Sanofi are a year behind their competitors in delivering a Covid-19 vaccine. They face an increasingly saturated market as they seek the FDA clearance for their jabs.
